Human BNP-specific antibodies
US6162902A · kind A · utility
35Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 1997 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Oct 1, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/841
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides reagents and assays for the quantification of hBNP in biological fluid samples such as plasma or serum. Antibodies are provided which are monospecific to epitopes comprising the amino acid sequences 5-13, 1-10 and 15-25 of hBNP. These antibodies, and peptide fragments containing these sequences, can be employed in the assays of the invention, which may be carried out in a sandwich format or a competition format.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.